Inflection Biosciences Overview
- Founded
- 2012

- Status
- Private
- Employees
- 10

- Latest Deal Type
- Later Stage VC
- Latest Deal Amount
- $367K

- Investors
- 3
Inflection Biosciences General Information
Description
Developer of small molecule therapeutics intended to help in the treatment of cancer. The company's therapeutics carries the potential for application in a range of treatments for solid tumors and hematological malignancies, enabling healthcare providers to treat their patients in an enhanced way.
Contact Information
- 1000 Massachusetts Avenue
- Cambridge, MA 02138
- United States
Inflection Biosciences Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Later Stage VC | 11-Aug-2019 | $367K | 00.00 | 00.000 | Completed | Pre-Clinical Trials |
3. Later Stage VC | 10-Apr-2018 | 000 | 00.000 | 00.000 | Completed | Pre-Clinical Trials |
2. Early Stage VC | 09-Mar-2015 | $913K | $1.53M | 00.000 | Completed | Pre-Clinical Trials |
1. Seed Round | 04-Jun-2013 | $615K | $615K | Completed | Startup |
Inflection Biosciences Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Ordinary | 00,000 | 00.000000 | 0000.00 | 0000.00 | 00 | 0000.00 | 00.000 | |
Ordinary | 0,000 | 00.000000 | 0000.00 | 0000.00 | 00 | 0000.00 | 0.000 |
Inflection Biosciences Comparisons
Industry
000000
00000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialInflection Biosciences Competitors (23)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Kineta | Venture Capital-Backed | Seattle, WA | 00 | 00000 | 0000000000 0 | 00000 |
000000000 | Formerly VC-backed | Gaithersburg, MD | 00 | 00000 | 00000000 | 00000 |
000000 00000000000 | Formerly VC-backed | South San Francisco, CA | 000 | 00000 | 00000000 | 00000 |
000000 00000000000 | Formerly VC-backed | Lexington, MA | 00 | 00000 | 00000000 | 00000 |
0000000 000000 | Venture Capital-Backed | Barcelona, Spain | 00 | 0000 | 000000000000 | 0000 |
Inflection Biosciences Executive Team (6)
Inflection Biosciences Board Members (7)
Name | Representing | Role | Since |
---|---|---|---|
Conor Mallaghan | Self | Board Member | 000 0000 |
Darren Cunningham | Inflection Biosciences | Co-Founder, Chief Executive Officer & Board Member | 000 0000 |
Gregory I. Berk MD | Self | Board Member | 000 0000 |
John Lynch | Self | Board Member | 000 0000 |
Michael O'Neill Ph.D | Inflection Biosciences | Co-Founder, Director of Research and Development & Board Member | 000 0000 |
Inflection Biosciences Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialInflection Biosciences Investors (3)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Fountain Healthcare Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
Michael Smurfit | Angel (individual) | Minority | 000 0000 | 000000 0 | |
Enterprise Ireland | Venture Capital | Minority | 000 0000 | 000000 0 |